US Patent Issued to BEIJING QL BIOPHARMACEUTICAL, LT on June 17 for "Fusion polypeptides for metabolic disorders" (Chinese Inventors)

ALEXANDRIA, Va., June 19 -- United States Patent no. 12,331,093, issued on June 17, was assigned to BEIJING QL BIOPHARMACEUTICAL CO., LT (Beijing).

"Fusion polypeptides for metabolic disorders" was invented by Yuanyuan Zhang (Beijing), Bo Wu (Beijing), Wei Guo (Beijing), Xiaona Dong (Beijing) and Yuying Zhang (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides conjugates of polypeptides comprising nanobody and FGF21 linked by a polypeptide linker. The present disclosure further provides conjugates of polypeptides comprising GLP-1, nanobody, and FGF21 linked by two polypeptide linkers respectively. Pharmaceutical compositions comprising the same and methods of treating dise...